Despite the pathophysiological and clinical differences between AD and PD, the basis for the use of GLP-1RAs in the treatment of these diseases is precisely the general mechanisms of their pathogenesis and risk factors, including T2DM and insulin resistance, abnormal accumulation of toxic proteins, increased inflammation, decreased synaptic function, loss of neurons, increased activation of astrocytes, leading to cognitive dysfunction [43]
Introduction Over the years, the poultry industry has improved genetics, nutrition, and management practices, resulting in fast-growing chickens that reach market weight faster than broilers raised decades ago ( in ovo delivery of bioactive substances
Do GLP-1 weight loss injections cause low blood sugar
In January 2024, Researchers from Tabriz University of Medical Sciences conducted a clinical trial emphasizing the synergistic anti-obesity effects of combining L-carnitine and synbiotics in women